Products for Research Use Only
RegisterLogin

Goserelin EP Impurity E

CAT: 0804-HY-P4454Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P4454Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Goserelin EP Impurity E is the impurity of Goserelin.
CAS Number
147688-42-4
UNSPSC
12352209
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Type
Peptides
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/goserelin-ep-impurity-e.html
Solubility
H2O
Smiles
O=C([C@H]1NC(CC1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(N[C@H](COC(C)(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N3[C@@H](CCC3)C(NN)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CNC6=CC=CC=C56)=O
Molecular Formula
C58H83N17O13
Molecular Weight
1226.39
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Kripa S. Srivastava, et al. Solid phase peptide synthesis process for the production of goserelin. Patent WO2010141276A1.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-137772Captopril EP Impurity E
HY-I0180A-01Ticagrelor EP Impurity E (hydrochloride)
HY-137772RCaptopril EP Impurity E (Standard)
HY-143982S-01Mianserin EP impurity E-d4 (hydrochloride)
HY-13673Goserelin
HY-13673SGoserelin-d10
HY-13673A-01Goserelin (acetate)
HY-13673S1Goserelin-d7
HY-P4759(D-His2) -Goserelin
HY-13673S2Goserelin-d7 (TFA)

Alternative Products

CatalogName
RM-G261041-01Goserelin Impurity 41
RM-G261022-01Goserelin Impurity 22
RM-G261033-01Goserelin Impurity 33
RM-G261015-01Goserelin Impurity O
AR-G01694-01Goserelin Impurity C
AR-G02726-01Goserelin Impurity 10
AR-G02724-01Goserelin Impurity 6
RM-G261021-01Goserelin Impurity 21
RM-G261014-01Goserelin Impurity N
RM-G261016-01Goserelin Impurity P

Popular Products